AzTrials
AzTrials

Osteoarthritis of the HipNCT02458144

Comparison of MIS Anterior Versus MIS Anterolateral Approach

A study testing Total hip arthroplasty in people with Osteoarthritis of the Hip, run by Medical University of Vienna at 1 site in Austria.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Aim of the present investigation is to analyse the amount of muscle trauma in relation to the surgical approach and to the individual postoperative functional recovery. The investigation will compare the MIS (minimally invasive surgery) anterior approach with the MIS anterolateral approach to the hip. Read more about this study

Who is it for?
Ages 50 to 80 years
Conditions the study is for
Osteoarthritis of the Hip
What is being tested?
Total hip arthroplasty
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteAustria
Study dates
Jan 2013to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • unilateral, noninflammatory end-stage osteoarthritis of the hip
  • willingness and ability to cooperate in the required post-operative therapy
  • willingness and ability to provide written informed consent
  • age 50-80 years

Who cannot join

  • inflammatory arthropathies
  • prior hip surgery
  • prior infection of the hip
  • severe morbidity
  • severe osteoporosis
  • inability to tolerate general anesthesia
Show all 10Show fewer
  • no contraindications to MRI e.g. pacemakers, claustrophobia
  • neuromuscular disorder, vascular disorder or other conditions that could contribute to prosthesis instability, prosthesis fixation failure, or complications in postoperative care
  • known alcohol or drug abuse
  • unwillingness to participate

Trial locations and contacts

1 site in 1 country.

Austria1 site, 1 recruiting
  • Department of Orthopaedics

    Vienna, State of Vienna, 1090

    Christoph Stihsen, Registrar, 0140400 ext. 40820, christoph.stihsen@meduniwien.ac.at

    Bernd Kubista, Consultant, 0140400 ext. 40820, bernd.kubista@meduniwien.ac.at

    Recruiting

Other trials in Austria

About this study

Official title: Comparison of Two Minimally Invasive Approaches to the Hip-anterior Versus Anterolateral - Which Technique is Less Invasive? A Prospective, Randomized, Controlled Pilot Study

Aim of the present investigation is to analyse the amount of muscle trauma in relation to the surgical approach and to the individual postoperative functional recovery. The investigation will compare the MIS (minimally invasive surgery) anterior approach with the MIS anterolateral approach to the hip.

Read the detailed description

The surgical approach to the hip is reportedly an important factor influencing implant stability and postsurgical muscle functioning. Reviewing the literature, controversial studies towards minimally invasive hip surgery can be found. Currently, none of the approaches can be considered superior, but the trend is towards minimally invasive techniques, as it is generally accepted that muscle trauma and damage of the periarticular structures should be minimized. However, a surgical approach that causes no damage to surrounding muscle is unrealistic. Whether the muscle is stretched, transacted or partially torn, injury will occur.

Aim of the present investigation is to analyse the amount of muscle trauma in relation to the surgical approach and to the individual postoperative functional recovery. The investigation will compare the MIS anterior approach with the MIS anterolateral approach to the hip. The investigators questioned, which technique would be the less invasive? Pain and functional performance will be measured using the Harris Hip Score, the Western Ontario McMaster, and the UCLA (University of California) Activity Score. Subject quality-of-life will be determined by evaluation the Short-Form 36 Health Survey. Standard radiographs of the hip are required to be captured before surgery and at 3, 6 and 12 months postoperatively. MRI scans will be performed to evaluate tendon defects, fatty atrophy and changes in the muscle cross-sectional area. Next, the patients will be referred for hip sonography, performed by a radiologist who is experienced in imaging of the musculoskeletal system who will be unaware of the clinical examination results of the patients. Moreover gait analyses will be performed preoperatively, 3 and 12 months after surgery. Pre- and postoperative standard blood tests and specific serum trauma markers will be obtained.

Being tested
Total hip arthroplasty
Medical subject headings
Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Total hip arthroplastyProcedure or surgery

    The minimally invasive anterior approach The patient is in supine position. The femoral neck is exposed in the interval between tensor fasciae latae, glutei medius and minimus muscles laterally, and sartorius and rectus femoris muscles medially. After osteotomy of the neck and extraction of the head the acetabulum is reamed to prepare for cup prosthesis. Following peritrochanteric capsulotomy the externally rotated, adducted and elevated femur is broached.

    The MIS anterolateral approach The MIS anterolateral technique is a modified Watson-Jones Approach. The patient is in supine position. This approach uses the intermuscular plane between the gluteus medius and the tensor fascia latae. After the anterior capsule is excised, a disc of the femoral neck is removed.

Study groups in NCT02458144
Study groupRoleWhat they receive
MIS "anterior" groupOtherTotal Hip Arthroplasty "anterior" surgical approach
Receives: Procedure: Total hip arthroplasty
MIS "anterolateral" groupOtherTotal Hip Arthroplasty "anterolateral" surgical approach
Receives: Procedure: Total hip arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MRI evaluation

    Cross-sectional area of gluteus medius and tensor fascia latae muscle (cm2)

    Measured: 12 months after surgery

Secondary outcomes (11)
  1. Harris Hip Score

    Points (0-100)

    Measured: 12 months after surgery

  2. Tendon defects of the hip abductors (cm) assessed by Ultrasound

    Tendon defects of the hip abductors (cm)

    Measured: 12 months after surgery

  3. Gait analysis

    posture of the pelvis, hip strength, range of motion

    Measured: 12 months after surgery

  4. Serum trauma marker 1

    creatinkinase (u/l)

    Measured: 1 hour preop. to 48 hours postop.

  5. Serum trauma marker 2

    interleukin-6 (pg/ml)

    Measured: 1 hour preop. to 48 hours postop.

  6. Serum trauma marker 3

    interleukin-1β (pg/ml)

    Measured: 1 hour preop. to 48 hours postop.

  7. Serum trauma marker 4

    lactate Dehydrogenase (u/l)

    Measured: 1 hour preop. to 48 hours postop.

  8. Serum trauma marker 5

    aldolase (u/l)

    Measured: 1 hour preop. to 48 hours postop.

  9. Serum trauma marker 6

    Myoglobin (ng/ml)

    Measured: 1 hour preop. to 48 hours postop.

  10. Serum trauma marker 7

    malondialdehyde (mg/dl)

    Measured: 1 hour preop. to 48 hours postop.

  11. Serum trauma marker 8

    glutathione (mg/dl)

    Measured: 1 hour preop. to 48 hours postop.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2015 (estimated)
  2. Study startJan 2013
  3. Primary completionAug 2016 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02458144
Sponsor's protocol ID
1392/2012
Status last verified
May 2015
First submitted
26 May 2015
Last updated
29 May 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Total hip arthroplasty in people with Osteoarthritis of the Hip, run by Medical University of Vienna at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Christoph Stihsen, Registrar (00431 40400 ext. 40820, christoph.stihsen@meduniwien.ac.at), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MRI evaluation (time frame: 12 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in